-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Provention Bio, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q1 2022.
- Provention Bio, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was -$7.06M.
- Provention Bio, Inc. annual Income Tax Expense (Benefit) for 2022 was -$13.4M, a 1239% decline from 2021.
- Provention Bio, Inc. annual Income Tax Expense (Benefit) for 2021 was -$1M, a 91.2% decline from 2020.
- Provention Bio, Inc. annual Income Tax Expense (Benefit) for 2020 was -$523K.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)